What is ALT5 Sigma Corporation's earnings per share (EPS)?

ALT5 Sigma Corporation (ALTS) reported diluted earnings per share of -$5.91 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

ALT5 Sigma Corporation (ALTS) Financials

ALTS

FY2025 annual

Revenue $24.8M +98.2% YoY

Net Income -$344.5M -4452.2% YoY

EPS (Diluted) -$5.91 YoY not available

Free Cash Flow -$7.2M YoY not available

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 28, 2026 Reported May 18, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q1 FY2026, filed May 18, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ALTS SEC filings page.

ALT5 Sigma Corporation (ALTS) reported $24.8M in revenue for fiscal year 2025, up 98.2% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ALTS FY2025 2026-08-29

The dominant mechanic is balance-sheet expansion through capital flows, while operating costs still outrun revenue growth.

FY2025's earnings-to-cash gap is unusually wide: a net loss of $344.5M accompanied operating cash flow of -$7.2M, so the reported loss was not a matching drain from core operations. Compared with FY2024, when operating cash flow was positive alongside a $7.6M net loss, the latest result points to a major noncash or non-operating component in reported earnings.

Revenue reached $24.8M in FY2025, while operating loss reached $22.9M; the near-doubling from FY2024 did not create operating leverage. Gross margin narrowed from 45.1% to 41.0%, so each added sales dollar carried less gross profit. SG&A reached $33.0M, indicating overhead growth absorbed much of the added sales.

FY2025 assets were $1.2B against $60.3M liabilities, making the capital structure overwhelmingly equity-funded rather than debt-funded. Yet current ratio was 0.6x, while reported liquidity equaled 10.4 months of annual outflow; substantial balance-sheet scale coexisted with tighter short-term coverage.

Financial Health Signals

Financial Health Score 23/100

Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of ALT5 Sigma Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway

ALT5 Sigma Corporation held $6.2M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $7.2M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and ALT5 Sigma Corporation scores 31/100 among other emerging companies.

Dilution

ALT5 Sigma Corporation had 126M shares outstanding at the end of fiscal year 2025. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and ALT5 Sigma Corporation scores 3/100 among other emerging companies.

R&D Intensity

Not available for ALT5 Sigma Corporation, and counted as zero in the overall score.

Revenue Progress

ALT5 Sigma Corporation reported revenue of $24.8M in fiscal year 2025, against $12.5M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and ALT5 Sigma Corporation scores 86/100 among other emerging companies.

Burn Trend

Not available for ALT5 Sigma Corporation, and counted as zero in the overall score.

Balance Sheet

ALT5 Sigma Corporation's cash, cash equivalents and investments came to $6.2M at the end of fiscal year 2025, against $60.3M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and ALT5 Sigma Corporation scores 17/100 among other emerging companies.

Altman Z-Score Distress

0.67

ALT5 Sigma Corporation scores 0.67, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($119.6M) relative to total liabilities ($60.3M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Weak

2/9

ALT5 Sigma Corporation passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality No Cash Backing

N/A

ALT5 Sigma Corporation reported a net loss of $344.5M while operations used $7.2M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$4.7M

YoY-2.8%

QoQ-22.0%

ALT5 Sigma Corporation generated $4.7M in revenue in Q1 2026. This represents a decrease of 2.8% from the same quarter a year earlier. Against the prior quarter it is down 22.0%.

EBITDA

-$1.9M

YoY-151.9%

ALT5 Sigma Corporation's EBITDA was -$1.9M in Q1 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 151.9% from the same quarter a year earlier.

Net Income

-$271.5M

YoY-11250.0%

QoQ+28.9%

ALT5 Sigma Corporation reported -$271.5M in net income in Q1 2026. This represents a decrease of 11250.0% from the same quarter a year earlier. Against the prior quarter it is up 28.9%.

EPS (Diluted)

-$2.14

ALT5 Sigma Corporation earned -$2.14 per diluted share (EPS) in Q1 2026.

Cash & Balance Sheet

Cash & Debt

$10.5M

YoY-2.7%

QoQ+69.1%

5Y CAGR+75.2%

10Y CAGR+11.5%

ALT5 Sigma Corporation held $10.5M in cash against $75K in long-term debt as of Q1 2026, with $39.1M of liabilities due within a year.

Shares Outstanding

127M

QoQ+0.8%

5Y CAGR+133.6%

10Y CAGR+36.2%

ALT5 Sigma Corporation had 127M shares outstanding in Q1 2026. Against the prior quarter it is up 0.8%.

Free Cash Flow

Not reported for Q1 2026.

Dividends Per Share

Not reported for Q1 2026.

Margins & Returns

Gross Margin

75.8%

YoY+36.1pp

QoQ+28.4pp

ALT5 Sigma Corporation's gross margin was 75.8% in Q1 2026, indicating the percentage of revenue retained after direct costs. This is up 36.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 28.4 percentage points.

Operating Margin

-58.2%

YoY-18.1pp

QoQ-20.6pp

ALT5 Sigma Corporation's operating margin was -58.2% in Q1 2026, reflecting core business profitability. This is down 18.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 20.6 percentage points.

Return on Equity

-30.5%

YoY-19.5pp

QoQ+2.7pp

ALT5 Sigma Corporation's ROE was -30.5% in Q1 2026, measuring profit generated per dollar of shareholder equity. This is down 19.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.7 percentage points.

Net Margin

Not shown for Q1 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

None of these metrics is reported for Q1 2026.

ALTS Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ALTS quarterly income statement

Metric	TTM	FY2510-K	FY24	FY23	FY22	FY22	FY21	FY19	FY18	FY17	FY16	FY16	FY15	FY13	FY12	FY11
Revenue	$24.7M	$24.8M+98.2%	$12.5M	$0-100.0%	$35.0M	$40.0M+18.2%	$33.9M	$35.1M-4.6%	$36.8M-11.4%	$41.5M+2.7%	$40.5M	$111.8M-14.6%	$130.9M	$127.9M+11.9%	$114.2M-9.8%	$126.7M
Cost of Revenue	$12.9M	$14.7M+134.9%	$6.2M	$0	$0	$31.2M+24.4%	$25.0M	$27.3M+6.1%	$25.7M-9.4%	$28.4M+1.1%	$28.1M	$86.4M-12.0%	$98.1M	$95.2M+12.1%	$84.9M-5.6%	$89.9M
Gross Profit	$11.8M	$10.2M+80.4%	$5.6M	$0	$0	$8.9M+0.5%	$8.8M	$7.8M-29.6%	$11.1M-15.9%	$13.1M+6.4%	$12.4M	$25.4M-22.4%	$32.8M	$32.7M+11.5%	$29.3M-20.2%	$36.7M
SG&A Expenses	$35.5M	$33.0M+162.8%	$12.6M+164.9%	$4.7M+50.7%	$3.1M	$12.1M-32.2%	$17.8M	$20.2M+17.9%	$17.1M+28.2%	$13.4M+19.0%	$11.2M	$29.6M-2.3%	$30.3M	$29.3M-6.9%	$31.5M+6.7%	$29.5M
Operating Income	-$23.6M	-$22.9M-230.1%	-$6.9M+65.1%	-$19.8M-530.2%	-$3.1M	-$16.8M-86.4%	-$9.0M	-$12.4M-103.9%	-$6.1M-2539.4%	-$231K-120.6%	$1.1M	-$4.1M-260.9%	$2.6M	$3.4M+205.4%	-$3.2M-144.5%	$7.2M
EBITDA	N/A	-$19.5M-248.0%	-$5.6M+69.5%	-$18.4M-484.5%	-$3.1M	-$12.6M-158.1%	-$4.9M	-$8.4M-298.0%	-$2.1M-209.6%	$1.9M-7.8%	$2.1M	-$2.8M-172.6%	$3.9M	$4.8M+338.1%	-$2.0M-123.4%	$8.5M
Interest Expense	N/A	N/A	N/A	$2.3M+380.8%	$468K	$773K+253.4%	-$504K	-$1.5M-321.6%	$668K-25.3%	$894K-23.5%	$1.2M	$1.3M+29.7%	$996K	$1.3M+9.8%	$1.1M+0.4%	$1.1M
Income Tax	-$171.6M	-$86.7M-54113.8%	-$160K+62.7%	-$429K+93.5%	-$6.6M	$273K-36.1%	$427K	-$3.2M-339.8%	-$727K+45.3%	-$1.3M-412.2%	$426K	-$1.7M-340.1%	$714K	-$1.4M-1796.4%	$83K-93.9%	$1.4M
Net Income	-$613.6M	-$344.5M-4452.2%	-$7.6M+3.1%	-$7.8M-171.1%	$11.0M	-$16.9M-98.7%	-$8.5M	-$12.0M-113.3%	-$5.6M-1383.6%	-$378K+78.6%	-$1.8M	-$3.9M-594.6%	$795K	$3.5M+177.7%	-$4.5M-194.4%	$4.7M
EPS (Basic)	N/A	-$5.91-769.1%	-$0.68+65.1%	-$1.95-155.9%	$3.49	-$6.35-38.3%	-$4.59	-$6.78-80.8%	-$3.75-18850.0%	$0.02+108.3%	-$0.24	-$0.47-435.7%	$0.14	$0.57+182.6%	-$0.69-185.2%	$0.81
EPS (Diluted)	—	-$5.91	-$0.68	-$1.95-155.9%	$3.49	-$6.35-38.3%	-$4.59	-$6.78	-$3.75-18850.0%	$0.02	-$0.24	-$0.47-461.5%	$0.13	$0.55+179.7%	-$0.69-189.6%	$0.77
Diluted Shares (Avg)	N/A	58M	11M	4M+41.1%	3M	3M+43.5%	2M	2M	1M-77.7%	7M	6M	6M+0.9%	6M	6M+3.4%	6M-4.6%	6M

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'24	Q2'24
Revenue	$4.7M-2.8%	$6.0M	$7.6M+53.3%	$6.4M+194.1%	$4.8M	N/A	$4.9M	$2.2M
Cost of Revenue	$1.1M-61.1%	$3.2M	$5.0M+91.9%	$3.6M+236.4%	$2.9M	N/A	$2.6M	$1.1M
Gross Profit	$3.6M+85.6%	$2.9M	$2.6M+11.1%	$2.8M+152.7%	$1.9M	N/A	$2.4M	$1.1M
SG&A Expenses	$6.3M+63.1%	$5.1M	$19.2M+519.5%	$4.9M+37.9%	$3.9M+114.4%	N/A	$3.1M+304.8%	$3.5M+221.4%
Operating Income	-$2.7M-41.0%	-$2.3M	-$16.5M-2159.4%	-$2.1M+13.9%	-$1.9M-7.8%	N/A	-$732K+4.2%	-$2.4M-121.5%
EBITDA	-$1.9M-151.9%	N/A	-$15.6M	N/A	-$736K+36.9%	N/A	N/A	N/A
Income Tax	-$85.1M-37713.3%	-$98.2M	$12.1M+3011.6%	-$432K+84.3%	-$225K-200.0%	N/A	-$415K-1560.0%	-$2.8M-1111.5%
Net Income	-$271.5M-11250.0%	-$382.0M	$49.0M+6056.4%	-$9.1M-1647.5%	-$2.4M-11.6%	N/A	-$822K-284.1%	$589K-94.2%
EPS (Basic)	-$2.14-1326.7%	N/A	$0.67+1216.7%	-$0.49-800.0%	-$0.15+55.9%	N/A	-$0.06-20.0%	$0.07-97.8%
EPS (Diluted)	-$2.14	N/A	$0.29	-$0.49	-$0.15	N/A	-$0.06	$0.07
Diluted Shares (Avg)	127M	N/A	169M	19M	16M	N/A	13M	8M

Not reported in any period shown, so not listed: R&D Expenses, Interest Expense.

ALTS Balance Sheet

ALTS quarterly balance sheet

Metric	FY2510-K	FY24	FY23	FY22	FY22	FY21	FY19	FY18	FY17	FY16	FY16	FY15	FY13	FY12	FY11
Total Assets	$1.2B+1510.2%	$75.7M+309.7%	$18.5M-60.5%	$46.8M	$16.5M-39.4%	$27.3M	$29.0M-17.1%	$35.0M-25.3%	$46.9M+12.0%	$41.9M	$45.0M-0.9%	$45.4M	$46.3M+10.7%	$41.8M-10.7%	$46.8M
Current Assets	$29.5M-14.3%	$34.4M+9832.4%	$346K-96.2%	$9.2M	$9.6M-8.5%	$10.5M	$8.8M-1.1%	$8.9M-57.7%	$21.1M-26.0%	$28.5M	$32.8M-1.3%	$33.2M	$33.4M+16.9%	$28.6M-10.5%	$31.9M
Cash & Equivalents	$6.2M-13.3%	$7.2M+143440.0%	$5K-91.8%	$61K	$2.3M-54.3%	$5.1M	$481K-59.7%	$1.2M-63.9%	$3.3M+242.3%	$968K	$2.3M-34.7%	$3.6M	$1.9M-38.6%	$3.2M-27.9%	$4.4M
Short-Term Investments	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory	N/A	N/A	N/A	$366K	$1.2M+24.0%	$1.0M	$1.3M+68.3%	$801K+5.1%	$762K-95.3%	$16.3M	$15.3M-4.8%	$16.0M	$16.7M-3.6%	$17.3M-6.4%	$18.5M
Accounts Receivable	N/A	$57K	$0-100.0%	$7.3M	$6.1M+64.5%	$3.7M	$7.2M+42.7%	$5.1M-49.5%	$10.0M-4.5%	$10.5M	$11.0M+16.9%	$9.4M	$12.3M+96.3%	$6.3M-16.0%	$7.4M
Long-Term Investments	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$12.3M+216.9%	$3.9M	$0	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$38K	$38K0.0%	$38K	$38K0.0%	$38K-96.6%	$1.1M
Total Liabilities	$60.3M+8.0%	$55.8M+155.9%	$21.8M-51.0%	$44.4M	$24.0M+27.8%	$18.8M	$18.7M+39.2%	$13.4M-35.0%	$20.7M-32.6%	$30.6M	$33.5M+5.2%	$31.9M	$31.6M+10.7%	$28.6M-2.9%	$29.4M
Current Liabilities	$51.4M+25.7%	$40.9M+592.7%	$5.9M-75.3%	$23.9M	$20.6M+17.8%	$17.5M	$17.6M+81.5%	$9.7M-38.6%	$15.8M-42.6%	$27.5M	$29.7M+12.4%	$26.5M	$24.6M+17.4%	$20.9M+2.3%	$20.4M
Non-Current Liabilities	$8.9M-40.5%	$14.9M-6.4%	$15.9M-22.5%	$20.5M	$3.5M+156.4%	$1.4M	$1.1M-70.1%	$3.7M-23.4%	$4.9M+53.3%	$3.2M	$3.8M-29.8%	$5.4M	$7.1M-7.7%	$7.6M-14.9%	$9.0M
Long-Term Debt	$563K0.0%	$563K	N/A	$1.3M	N/A	N/A	N/A	N/A	$0-100.0%	$4.5M	$3.5M-14.4%	$4.0M	$6.6M-10.0%	$7.3M+0.8%	$7.3M
Total Equity	$1.2B+9152.5%	$12.4M+476.3%	-$3.3M-243.4%	$2.3M	-$7.5M-188.5%	$8.5M	$10.3M-52.1%	$21.6M-17.6%	$26.2M+142.8%	$10.8M	$10.9M-7.9%	$11.9M	$12.7M+9.4%	$11.6M-23.3%	$15.2M
Retained Earnings	-$402.7M-591.9%	-$58.2M-14.9%	-$50.6M-18.2%	-$42.8M	-$52.6M-44.4%	-$36.4M	-$28.4M-72.0%	-$16.5M-51.4%	-$10.9M+1.1%	-$11.0M	-$10.0M-17.1%	-$8.6M	-$7.6M+29.2%	-$10.8M-124.7%	-$4.8M

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'24	Q2'24
Total Assets	$959.7M+1130.2%	$1.2B+1510.2%	$1.6B+2090.0%	$94.7M+25.6%	$78.0M+319.9%	$75.7M+309.7%	$74.9M+117.1%	$75.4M+115.6%
Current Assets	$32.2M+1.3%	$29.5M-14.3%	$44.8M+40.5%	$33.7M+9.3%	$31.8M+2569.6%	$34.4M+9832.4%	$31.9M+6069.6%	$30.9M+4748.5%
Cash & Equivalents	$10.5M-2.7%	$6.2M-13.3%	$7.3M-15.6%	$9.6M+65.9%	$10.8M+17623.0%	$7.2M+143440.0%	$8.7M+1999.0%	$5.8M+1532.9%
Accounts Receivable	N/A	N/A	$439K-48.5%	N/A	N/A	$57K	$853K	$865K
Goodwill	$12.3M+5.0%	$12.3M+216.9%	$20.1M+160.6%	$20.1M+160.6%	$11.7M	$3.9M	$7.7M	$7.7M
Total Liabilities	$62.6M+28.2%	$60.3M+8.0%	$80.1M+57.6%	$61.6M+26.7%	$48.8M+229.8%	$55.8M+155.9%	$50.8M+154.1%	$48.6M+127.0%
Current Liabilities	$39.1M+2.3%	$51.4M+25.7%	$56.4M+33.2%	$38.3M-10.0%	$38.2M+373.0%	$40.9M+592.7%	$42.3M+1590.4%	$42.5M+1122.6%
Non-Current Liabilities	$23.5M+121.2%	$8.9M-40.5%	$23.7M+179.4%	$23.3M+282.2%	$10.6M+58.0%	$14.9M-6.4%	$8.5M-51.5%	$6.1M-66.0%
Long-Term Debt	$75K	$563K0.0%	N/A	N/A	N/A	$563K	N/A	N/A
Total Equity	$889.7M+3975.8%	$1.2B+9152.5%	$1.6B+7578.0%	$26.1M+13.6%	$21.8M+478.6%	$12.4M+476.3%	$20.2M+39.5%	$22.9M+69.1%
Retained Earnings	-$674.1M-1028.4%	-$402.7M-591.9%	-$19.9M+62.5%	-$68.9M-31.9%	-$59.7M-13.2%	-$58.2M-14.9%	-$53.0M-61.5%	-$52.2M-59.4%

Not reported in any period shown, so not listed: Short-Term Investments, Inventory, Long-Term Investments.

ALTS Cash Flow Statement

ALTS quarterly cash flow statement

Metric	TTM	FY2510-K	FY24	FY23	FY22	FY22	FY21	FY19	FY18	FY17	FY16	FY16	FY15	FY13	FY12	FY11
Operating Cash Flow	-$18.0M	-$7.2M-502.8%	$1.8M+21.5%	$1.5M+147.9%	-$3.1M	-$5.3M-757.7%	-$617K	-$3.5M-184.7%	$4.1M+238.1%	$1.2M-53.9%	$2.7M	-$3.4M-194.8%	$3.6M	$1.7M+215.8%	$551K-60.0%	$1.4M
Depreciation & Amortization	N/A	$3.3M+153.7%	$1.3M-9.4%	$1.5M+72500.0%	$2K	$4.2M+1.7%	$4.1M	$4.1M+2.0%	$4.0M+86.2%	$2.1M+123.9%	$959K	$1.3M-6.3%	$1.4M	$1.4M+12.1%	$1.2M-6.3%	$1.3M
Stock-Based Compensation	N/A	$5.9M+158.2%	$2.3M+16221.4%	$14K+180.0%	$5K	$303K-47.6%	$578K	$631K-3.8%	$656K+141.2%	$272K+11.0%	$245K	$316K+18.4%	$267K	$233K+52.3%	$153K-64.3%	$428K
Capital Expenditures	N/A	$11K	N/A	N/A	$808K	$1.7M+227.2%	$507K	$212K-47.1%	$401K+1722.7%	$22K-94.1%	$375K	$404K-50.6%	$818K	$501K-38.8%	$818K-53.4%	$1.8M
Free Cash Flow	N/A	-$7.2M	N/A	N/A	-$3.9M	-$7.0M-518.4%	-$1.1M	-$3.7M-199.4%	$3.7M+211.0%	$1.2M-47.3%	$2.3M	-$3.8M-237.3%	$2.8M	$1.2M+564.0%	-$267K+29.9%	-$381K
Investing Cash Flow	N/A	-$706.6M-12172.5%	$5.9M+3876.1%	-$155K+89.7%	-$1.5M	-$1.7M-106.4%	-$834K	$345K+300.6%	-$172K-102.3%	$7.3M+1878.9%	-$412K	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	$723.8M	$716.8M+11664.3%	$6.1M+524.6%	-$1.4M-136.1%	$4.0M	$7.4M+424.8%	$1.4M	$2.5M+140.3%	-$6.1M+2.5%	-$6.3M-94.4%	-$3.2M	N/A	N/A	N/A	N/A	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'24	Q2'24
Operating Cash Flow	-$12.3M-763.9%	$8.3M+525.7%	-$8.7M-308.4%	-$5.3M-6730.0%	-$1.4M-161.6%	-$2.0M-377.3%	$4.2M+1055.1%	$80K-96.7%
Depreciation & Amortization	$889K-26.5%	N/A	$928K	N/A	$1.2M+89.4%	N/A	N/A	N/A
Stock-Based Compensation	N/A	N/A	N/A	N/A	$0-100.0%	N/A	N/A	N/A
Capital Expenditures	N/A	-$5K	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	$8.3M	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	$4.7M	-$711.4M	$122K-97.9%	$0	$0-100.0%	$0	$5.9M+3851.9%
Financing Cash Flow	$8.5M+451.6%	-$2.6M-164.5%	$715.7M+79420.7%	$2.2M+274.2%	$1.5M+157.3%	$4.0M	$900K+31.8%	$577K+128.2%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

ALTS Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ALTS quarterly financial ratios

Metric	FY2510-K	FY24	FY23	FY22	FY22	FY21	FY19	FY18	FY17	FY16	FY16	FY15	FY13	FY12	FY11
Gross Margin	41.0%-4.1pp	45.1%	N/A	0.0%	22.2%-3.9pp	26.1%	22.2%-7.9pp	30.0%-1.6pp	31.6%+1.1pp	30.6%	22.8%-2.3pp	25.1%	25.6%-0.1pp	25.7%-3.3pp	29.0%
Operating Margin	-92.0%-36.8pp	-55.2%	N/A	-9.0%	-41.9%-15.3pp	-26.6%	-35.4%-18.9pp	-16.6%-16.0pp	-0.6%-3.3pp	2.8%	-3.7%-5.6pp	1.9%	2.7%+5.5pp	-2.8%-8.5pp	5.7%
Net Margin	-1386.9%	-60.4%	N/A	31.4%	-42.2%-17.1pp	-25.1%	-34.1%-18.8pp	-15.2%-14.3pp	-0.9%+3.5pp	-4.4%	-3.5%-4.1pp	0.6%	2.7%+6.6pp	-3.9%-7.6pp	3.7%
Return on Equity	-29.9%+30.9pp	-60.8%	N/A	476.5%	N/A	-100.1%	-115.7%-89.7pp	-25.9%-24.5pp	-1.4%+14.9pp	-16.3%	-36.0%-42.7pp	6.7%	27.2%+65.5pp	-38.3%-69.4pp	31.1%
Return on Assets	-28.2%-18.3pp	-10.0%+32.3pp	-42.3%-65.8pp	23.5%	-102.1%-71.0pp	-31.1%	-41.2%-25.2pp	-16.0%-15.2pp	-0.8%+3.4pp	-4.2%	-8.7%-10.5pp	1.8%	7.5%+18.1pp	-10.7%-20.8pp	10.1%
Current Ratio	0.57-0.3x	0.84+0.8x	0.06-0.3x	0.38	0.47-0.1x	0.60	0.50-0.4x	0.92-0.4x	1.34+0.3x	1.04	1.10-0.2x	1.25	1.360.0x	1.36-0.2x	1.56
Debt-to-Equity	0.000.0x	0.05	N/A	0.58	N/A	2.22	1.81+1.2x	0.62+0.6x	0.00-0.4x	0.41	0.320.0x	0.34	0.52-0.1x	0.63+0.2x	0.48
Asset Turnover	0.02-0.1x	0.17+0.2x	0.00-0.7x	0.75	2.42+1.2x	1.24	1.21+0.2x	1.05+0.2x	0.89-0.1x	0.97	2.48-0.4x	2.88	2.760.0x	2.730.0x	2.71
FCF Margin	-28.9%	N/A	N/A	-11.0%	-17.4%-14.0pp	-3.3%	-10.6%-20.8pp	10.2%+7.3pp	2.9%-2.8pp	5.7%	-3.4%-5.5pp	2.1%	1.0%+1.2pp	-0.2%+0.1pp	-0.3%

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'24	Q2'24
Gross Margin	75.8%+36.1pp	47.4%	34.6%-13.2pp	43.5%-7.1pp	39.7%	N/A	47.8%	50.6%
Operating Margin	-58.2%-18.1pp	-37.6%	-218.3%	-32.9%	-40.1%	N/A	-14.8%	-112.2%
Net Margin	-5761.7%	-6326.0%	646.4%	-142.9%	-49.3%	N/A	-16.6%	27.2%
Return on Equity	-30.5%-19.5pp	-33.2%	3.1%+7.2pp	-35.0%-37.6pp	-11.0%+45.9pp	N/A	-4.1%-2.6pp	2.6%-71.8pp
Return on Assets	-28.3%-25.2pp	-31.3%	3.0%+4.1pp	-9.6%-10.4pp	-3.1%+8.5pp	N/A	-1.1%-0.5pp	0.8%-28.1pp
Current Ratio	0.820.0x	0.57-0.3x	0.790.0x	0.88+0.2x	0.83+0.7x	0.84+0.8x	0.75+0.5x	0.73+0.5x
Debt-to-Equity	0.00-2.2x	0.000.0x	0.05-2.5x	2.36+0.2x	2.24-1.7x	0.05	2.51+1.1x	2.12+0.5x
Asset Turnover	0.00-0.1x	0.01	0.00-0.1x	0.070.0x	0.06+0.1x	N/A	0.07+0.1x	0.030.0x
FCF Margin	N/A	137.5%	N/A	N/A	N/A	N/A	N/A	N/A

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Note: The current ratio is below 1.0 (0.57), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
ALT5 Sigma Corporation ALTS	FY2025	$24.8M	-$344.5M	N/A	$119.6M	23/100
Digital Turbine, Inc. APPS	FY2026	$565.3M	-$37.7M	-6.7%	$1.3B	24/100
Mitek Systems, Inc. MITK	FY2025	$179.7M	$8.8M	4.9%	$754.9M	60/100
AMTD Digital Inc. HKD	FY2025	$136.1M	$97.0M	71.3%	$537.4M	58/100
Cerence Inc. CRNC	FY2025	$251.8M	-$18.7M	-7.4%	$349.6M	27/100
PubMatic, Inc. PUBM	FY2025	$282.9M	-$14.0M	-5.0%	$799.4M	43/100

Where ALT5 Sigma Corporation Ranks

Frequently Asked Questions

What is ALT5 Sigma Corporation's annual revenue?

ALT5 Sigma Corporation (ALTS) reported $24.8M in total revenue for fiscal year 2025. This represents a 98.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is ALT5 Sigma Corporation's revenue growing?

ALT5 Sigma Corporation (ALTS) revenue grew by 98.2% year-over-year, from $12.5M to $24.8M in fiscal year 2025.

Is ALT5 Sigma Corporation profitable?

No, ALT5 Sigma Corporation (ALTS) reported a net income of -$344.5M in fiscal year 2025.

What is ALT5 Sigma Corporation's EBITDA?

ALT5 Sigma Corporation (ALTS) had EBITDA of -$19.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does ALT5 Sigma Corporation have?

As of fiscal year 2025, ALT5 Sigma Corporation (ALTS) had $6.2M in cash and equivalents against $563K in long-term debt.

What is ALT5 Sigma Corporation's gross margin?

ALT5 Sigma Corporation (ALTS) had a gross margin of 41.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is ALT5 Sigma Corporation's operating margin?

ALT5 Sigma Corporation (ALTS) had an operating margin of -92.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is ALT5 Sigma Corporation's return on equity (ROE)?

ALT5 Sigma Corporation (ALTS) has a return on equity of -29.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is ALT5 Sigma Corporation's free cash flow?

ALT5 Sigma Corporation (ALTS) recorded an outflow of $7.2M in free cash flow during fiscal year 2025. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is ALT5 Sigma Corporation's operating cash flow?

ALT5 Sigma Corporation (ALTS) recorded an outflow of $7.2M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are ALT5 Sigma Corporation's total assets?

ALT5 Sigma Corporation (ALTS) had $1.2B in total assets as of fiscal year 2025, including both current and long-term assets.

What are ALT5 Sigma Corporation's capital expenditures?

ALT5 Sigma Corporation (ALTS) invested $11K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does ALT5 Sigma Corporation have outstanding?

ALT5 Sigma Corporation (ALTS) had 126M shares outstanding as of fiscal year 2025.

What is ALT5 Sigma Corporation's current ratio?

ALT5 Sigma Corporation (ALTS) had a current ratio of 0.57 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is ALT5 Sigma Corporation's debt-to-equity ratio?

ALT5 Sigma Corporation (ALTS) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is ALT5 Sigma Corporation's return on assets (ROA)?

ALT5 Sigma Corporation (ALTS) had a return on assets of -28.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

How does ALT5 Sigma Corporation's liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, ALT5 Sigma Corporation (ALTS) held $6.2M in cash, cash equivalents and investments, and reported an operating cash outflow of $7.2M over that year. Dividing the one by the other, the reported balance equals about 10 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is ALT5 Sigma Corporation's Altman Z-Score?

ALT5 Sigma Corporation (ALTS) has an Altman Z-Score of 0.67, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is ALT5 Sigma Corporation's Piotroski F-Score?

ALT5 Sigma Corporation (ALTS) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are ALT5 Sigma Corporation's earnings high quality?

ALT5 Sigma Corporation (ALTS) reported a net loss of $344.5M while operations used $7.2M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is ALT5 Sigma Corporation?

ALT5 Sigma Corporation (ALTS) scores 23 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.